GetTopicDetailResponse(id=06ba904986e, topicName=西尼莫德, introduction=西尼莫德, content=null, image=null, comments=2, allHits=1069, url=https://h5.medsci.cn/topic?id=90498, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=103394, tagList=[TagDto(tagId=103394, tagName=西尼莫德)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1743349, encodeId=82241e433492b, content=<a href='/topic/show?id=06ba904986e' target=_blank style='color:#2F92EE;'>#西尼莫德#</a>, objectTitle=華山陳向軍、俞海：西尼莫德帶給中國多發(fā)性硬化患者前沿療法，新藥研發(fā)可從四個方向突破, objectType=article, longId=200726, objectId=135f200e2611, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=135f200e2611, replyNumber=0, likeNumber=62, createdTime=2020-10-22, rootId=0, userName=shuangle, userId=ab8035100004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=135f200e2611, moduleTitle=華山陳向軍、俞海：西尼莫德帶給中國多發(fā)性硬化患者前沿療法，新藥研發(fā)可從四個方向突破, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=135f200e2611)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743348, encodeId=c5d11e43348a8, content=<a href='/topic/show?id=06ba904986e' target=_blank style='color:#2F92EE;'>#西尼莫德#</a>, objectTitle=NMPA：多發(fā)性硬化的S1P靶向治療藥物西尼莫德批準上市, objectType=article, longId=194138, objectId=e8bf19413837, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8bf19413837, replyNumber=0, likeNumber=94, createdTime=2020-08-24, rootId=0, userName=shuangle, userId=ab8035100004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8bf19413837, moduleTitle=NMPA：多發(fā)性硬化的S1P靶向治療藥物西尼莫德批準上市, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e8bf19413837)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
